CSIMarket
 


Cumberland Pharmaceuticals Inc   (CPIX)
Other Ticker:  
 
 

CPIX's Capital Expenditures Growth by Quarter and Year

Cumberland Pharmaceuticals Inc 's Capital Expenditures results by quarter and year




CPIX Capital Expenditures (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - 0.35 2.69 0.47
III Quarter September - 0.18 0.86 0.44
II Quarter June - 0.09 0.10 0.32
I Quarter March 0.57 0.39 0.63 0.58
FY   0.57 1.01 4.28 1.81



CPIX Capital Expenditures first quarter 2019 Y/Y Growth Comment
Cumberland Pharmaceuticals Inc achieved in the first quarter, above Company average Capital Expenditures rise of 46.45% year on year, to $ 0.57 millions.

Looking into first quarter results within Major Pharmaceutical Preparations industry 39 other companies have achieved higher Capital Expenditures growth. While Cumberland Pharmaceuticals Inc ' s Capital Expenditures jump of 46.45% ranks overall at the positon no. 427 in the first quarter.




CPIX Capital Expenditures ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - -86.99 % 472.34 % -2.08 %
III Quarter September - -79.07 % 95.45 % -12 %
II Quarter June - -10 % -68.75 % -28.89 %
I Quarter March 46.45 % -38.1 % 8.62 % -17.14 %
FY   - -76.4 % 136.46 % -15.02 %

Financial Statements
Cumberland Pharmaceuticals Inc 's first quarter 2019 Capital Expenditures $ 0.57 millions CPIX's Income Statement
Cumberland Pharmaceuticals Inc 's first quarter 2018 Capital Expenditures $ 0.39 millions Quarterly CPIX's Income Statement
New: More CPIX's historic Capital Expenditures Growth >>


CPIX Capital Expenditures (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - 94.44 % 212.79 % 6.82 %
III Quarter September - 100 % 760 % 37.5 %
II Quarter June - -76.92 % -84.13 % -44.83 %
I Quarter March 63.19 % -85.5 % 34.04 % 20.83 %
FY (Year on Year)   - -76.4 % 136.46 % -15.02 %




Capital Expenditures first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #40
Healthcare Sector #115
Overall #427

Capital Expenditures Y/Y Growth Statistics
High Average Low
107.73 % 4.27 % -69.63 %
(Dec 31 2018)   (Dec 31 2019)
Capital Expenditures first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #40
Healthcare Sector #115
Overall #427
Capital Expenditures Y/Y Growth Statistics
High Average Low
107.73 % 4.27 % -69.63 %
(Dec 31 2018)   (Dec 31 2019)

Capital Expenditures by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Cumberland Pharmaceuticals Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
785.47 % 51.96 % -100 %
(Sep 30 2018)  


CPIX's I. Quarter Q/Q Capital Expenditures Comment
Cumberland Pharmaceuticals Inc achieved in the I. Quarter 2019 above company average sequential Capital Expenditures jump of 63.19%, to $ 0.57 millions, from $0.35 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry 44 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Cumberland Pharmaceuticals Inc 's Capital Expenditures growth quarter on quarter, overall rank is 397.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #45
Healthcare Sector #117
Overall #397
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #45
Healthcare Sector #117
Overall #397
Capital Expenditures Q/Q Growth Statistics
High Average Low
785.47 % 51.96 % -100 %
(Sep 30 2018)  


CPIX's I. Quarter Q/Q Capital Expenditures Comment
Cumberland Pharmaceuticals Inc achieved in the I. Quarter 2019 above company average sequential Capital Expenditures jump of 63.19%, to $ 0.57 millions, from $0.35 millions in the forth quarter.

Within Major Pharmaceutical Preparations industry 44 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Cumberland Pharmaceuticals Inc 's Capital Expenditures growth quarter on quarter, overall rank is 397.


Cumberland Pharmaceuticals Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Capital Expenditures 12 Months Ending $ 1.20 $ 1.02 $ 3.36 $ 4.03 $ 4.04
Y / Y Capital Expenditures Growth (TTM) -70.31 % -76.16 % 63.07 % 206.37 % 162.4 %
Year on Year Capital Expenditures Growth Overall Ranking # 2407 # 2908 # 483 # 176 # 270
Seqeuential Capital Expenditures Change (TTM) 17.66 % -69.63 % -16.81 % -0.1 % -5.54 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 427 # 3091 # 2045 # 1569 # 2059




Cumulative Capital Expenditures growth Comment
Cumberland Pharmaceuticals Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Dec 31 2019. If the fiscal year would end in Mar 31 2020, Cumberland Pharmaceuticals Inc 's annual Capital Expenditures decline would be -70.31% year on year to $1 millions.

In the Healthcare sector 352 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 2407, from total ranking in previous quarter at 2908.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
107.73 %
4.27 %
-69.63 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 40
Healthcare Sector # 353
Overall # 2407

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
206.37 %
39.72 %
-80.23 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 115
S&P 500 # 427
Cumulative Capital Expenditures growth Comment
Cumberland Pharmaceuticals Inc showed decline, but improvement compare to trailing twelve month Capital Expenditures decrease in Dec 31 2019. If the fiscal year would end in Mar 31 2020, Cumberland Pharmaceuticals Inc 's annual Capital Expenditures drop would be -70.31% year on year to $1 millions.

In the Healthcare sector 352 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 2407, from total ranking in previous quarter at 2908.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
107.73 %
4.27 %
-69.63 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 40
Healthcare Sector # 353
Overall # 2407

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
206.37 %
39.72 %
-80.23 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 40
Sector # 115
S&P 500 # 427




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
CPIX's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for CPIX's Competitors
Capital Expenditures Growth for Cumberland Pharmaceuticals Inc 's Suppliers
Capital Expenditures Growth for CPIX's Customers

You may also want to know
CPIX's Annual Growth Rates CPIX's Profitability Ratios CPIX's Asset Turnover Ratio CPIX's Dividend Growth
CPIX's Roe CPIX's Valuation Ratios CPIX's Financial Strength Ratios CPIX's Dividend Payout Ratio
CPIX's Roa CPIX's Inventory Turnover Ratio CPIX's Growth Rates CPIX's Dividend Comparisons



Companies with similar Capital Expenditures drop for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Mar 31 2020
Regional Health Properties Inc   80.46 %$ 80.460 millions
Apollo Endosurgery inc   79.66 %$ 79.661 millions
Xencor Inc  78.10 %$ 78.104 millions
Quest Diagnostics Inc  76.60 %$ 76.596 millions
Alector Inc   75.67 %$ 75.665 millions
Teladoc Health inc   75.33 %$ 75.329 millions
Brainstorm Cell Therapeutics Inc   75.00 %$ 75.000 millions
Idera Pharmaceuticals Inc   75.00 %$ 75.000 millions
Siga Technologies Inc  73.18 %$ 73.176 millions
Nabriva Therapeutics Plc  71.43 %$ 71.429 millions
Avrobio Inc   69.71 %$ 69.706 millions
Cellectar Biosciences Inc   69.06 %$ 69.064 millions
Harvard Bioscience Inc  68.53 %$ 68.531 millions
Atara Biotherapeutics Inc   67.46 %$ 67.462 millions
Electromed Inc   66.91 %$ 66.915 millions
Alimera Sciences Inc  66.67 %$ 66.667 millions
Rockwell Medical Inc   66.43 %$ 66.428 millions
Merck and Co Inc   65.71 %$ 65.714 millions
Allergan plc  63.21 %$ 63.209 millions
Rigel Pharmaceuticals Inc  61.01 %$ 61.008 millions
Capital Senior Living Corp  59.59 %$ 59.588 millions
Radnet Inc   55.36 %$ 55.364 millions
Charles River Laboratories International inc   53.73 %$ 53.733 millions
Cohbar Inc   53.61 %$ 53.614 millions
Voyager Therapeutics Inc   53.46 %$ 53.462 millions
Bausch Health Companies Inc   53.19 %$ 53.191 millions
Biomarin Pharmaceutical Inc  53.07 %$ 53.071 millions
Molecular Templates Inc   50.08 %$ 50.080 millions
Livanova Plc  49.75 %$ 49.747 millions
Zoetis Inc   49.21 %$ 49.206 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HY's Profile

Stock Price

HY's Financials

Business Description

Fundamentals

Charts & Quotes

HY's News

Suppliers

HY's Competitors

Customers & Markets

Economic Indicators

HY's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071